CD22 / APC-Cy7 / hL22 (Epratuzumab)

Product Details
Supplier Absolute Antibody
Catalog #: Ab00728-36.0-apc/cy7 (View supplier product page)
Size 200 μg
Price
Antigen CD22
Clone hL22 (Epratuzumab)
Host Cyno Macaque
Isotype IgG4
Conjugate APC-Cy7
Target Species Cynomolgus macaque, Human, Rhesus macaque
Applications Block/Neutralize, IP, FC
Description Anti-CD22 [hL22 (Epratuzumab)]
About CD22 and APC-Cy7
CD22 Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome. [provided by Alliance of Genome Resources, Apr 2022]
APC-Cy7 APC-Cy7 (APC-Cyanine 7) has an excitation peak at 650 nm and an emission peak at 785 nm, and is spectrally similar to APC-CF®750 (Biotium), APC-H7 (BD Biosciences), APC-eFluor™ 780 (Thermo Fisher Scientific), APC-Vio®770 (Miltenyi Biotec) and APC-Fire™ 750 (BioLegend). This dye is a member of the Cyanine® dye family, a trademark of GE heathcare.
Citations
Additional
Sources
Reviews & Ratings
APC-Cy7 Excitation and Emission Spectra